Vanderschueren D, Van Herck E, Suiker A M, Visser W J, Schot L P, Bouillon R
Laboratorium voor Experimentele Geneeskunde en Endocrinologie, Katholieke Universiteit, Leuven, Belgium.
Endocrinology. 1992 May;130(5):2906-16. doi: 10.1210/endo.130.5.1572302.
Both short and long term effects of androgen deficiency and steroid replacement therapy on skeletal homeostasis were investigated in aged (13-month-old) male rats. The animals were either sham operated (n = 28) or orchidectomized (orch; n = 89). The orch animals were divided into 5 groups; 26 rats received an empty sc Silastic implant (orch), all others received an implant containing testosterone (T), 5 alpha-dihydrotestosterone (DHT), 17 beta-estradiol (E2), or nandrolone (Nandro; 15-16 rats in each group). Half of the rats were killed 1 month (short term experiment) after implantation; the others were killed 4 months after implantation (long term experiment). Short term androgen deficiency caused a significant increase in both serum osteocalcin and histomorphometric parameters of bone turnover measured at the proximal tibial metaphysis, but not in a significant decrease in bone mass at this site. This increase in bone turnover was prevented not only by T and DHT, but also by E2 and Nandro. Long term androgen deficiency resulted in a decrease in the calcium content of both tibia and lumbar vertebrae. Cancellous bone volume in the proximal tibial metaphysis was +/- 50% lower in the orch group (P less than 0.001) 4 months after orchidectomy. At the same time, cortical bone was lost in orch rats; femoral cortical thickness was reduced by 12% (P less than 0.01), and cortical density tended to be lower. T, DHT, E2, or Nandro treatment completely prevented this decrease in cortical thickness and density. T and Nandro were also able to prevent the cancellous bone loss. DHT could only partly prevent cancellous bone loss. E2 treatment resulted not only in a sustained decrease in both serum osteocalcin concentrations and histomorphometric indices of bone turnover, but also in a net gain of cancellous bone volume (P less than 0.05 vs. sham). No significant differences in serum concentrations of vitamin D metabolites or nephrogenous cAMP were observed between groups in both short and long term experiments. We conclude that bone mass in aged male rats was significantly decreased 4 months after orchidectomy, preceded by an early increase in bone turnover. Both the early increase in bone turnover and the later decrease in bone mass were prevented by aromatizable and nonaromatizable androgens by estrogen and by nandralone.
在老年(13 个月大)雄性大鼠中研究了雄激素缺乏和类固醇替代疗法对骨骼稳态的短期和长期影响。将动物分为假手术组(n = 28)或去势组(orch;n = 89)。去势动物分为 5 组;26 只大鼠接受皮下空的硅橡胶植入物(去势组),其他所有大鼠接受含有睾酮(T)、5α-双氢睾酮(DHT)、17β-雌二醇(E2)或诺龙(Nandro;每组 15 - 16 只大鼠)的植入物。一半大鼠在植入后 1 个月处死(短期实验);另一半在植入后 4 个月处死(长期实验)。短期雄激素缺乏导致血清骨钙素和胫骨近端干骺端骨转换的组织形态计量学参数显著增加,但该部位骨量无显著减少。这种骨转换增加不仅被 T 和 DHT 阻止,也被 E2 和 Nandro 阻止。长期雄激素缺乏导致胫骨和腰椎钙含量降低。去势组在去势 4 个月后,胫骨近端干骺端的松质骨体积比假手术组低约 50%(P < 0.001)。同时,去势大鼠的皮质骨丢失;股骨皮质厚度减少 12%(P < 0.01),皮质密度趋于降低。T、DHT、E2 或 Nandro 治疗完全阻止了皮质厚度和密度的这种降低。T 和 Nandro 也能够阻止松质骨丢失。DHT 只能部分阻止松质骨丢失。E2 治疗不仅导致血清骨钙素浓度和骨转换的组织形态计量学指标持续降低,还导致松质骨体积净增加(与假手术组相比,P < 0.05)。在短期和长期实验中,各组之间维生素 D 代谢产物或肾源性环磷酸腺苷的血清浓度均未观察到显著差异。我们得出结论,老年雄性大鼠在去势 4 个月后骨量显著降低,在此之前骨转换早期增加。骨转换的早期增加和后期骨量的减少均被可芳香化和不可芳香化的雄激素、雌激素和诺龙阻止。
Calcif Tissue Int. 1994-9
Int J Hematol Oncol Stem Cell Res. 2019-10-1
J Bone Miner Metab. 2018-11-3
Int J Endocrinol Metab. 2018-7-2
Yonsei Med J. 2016-11
Int J Endocrinol. 2014-7-23